By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2910 Seventh Street

Berkeley  California  94710  U.S.A.
Phone: 510-204-7200 or 800-BIO-XOMA
Fax: 510-644-0539



Company News
XOMA  (XOMA) Announces Positive Results From Its Phase II Proof-Of-Concept Study Of Prolactin Inhibition 4/24/2017 11:24:21 AM
XOMA  (XOMA) To Present At The Jefferies Global Healthcare Conference 6/3/2016 7:53:14 AM
Embattled Bay Area XOMA  (XOMA) Terminates Gevokizumab Trials 3/11/2016 6:39:17 AM
XOMA  (XOMA) To Present At The Cowen and Company Health Care Conference 3/3/2016 7:54:01 AM
Agenus (AGEN) Completes XOMA  (XOMA) Antibody Manufacturing Pilot Plant Acquisition 1/4/2016 11:21:13 AM
Novo Nordisk A/S (NVO) Breathes New Life into XOMA  (XOMA) with $295 Million Diabetes Pact 12/1/2015 7:05:32 AM
XOMA  (XOMA) To Present At Two Upcoming Investor Conferences 11/13/2015 9:30:44 AM
Struggling XOMA  (XOMA) Sells Biologics Manufacturing Facilities to Agenus (AGEN), Divests Biodefense Program to Nanotherapeutics 11/6/2015 5:55:05 AM
XOMA  (XOMA) To Announce Third Quarter 2015 Financial Results And Host Webcast On November 5 10/30/2015 8:04:58 AM
XOMA  (XOMA) Initiates Proof-Of-Concept Study For XOMA 358 In Patients With Congenital Hyperinsulinism 10/26/2015 7:17:11 AM